Formidable Asset Management, LLC
Position in CORT — Corcept Therapeutics Inc
CIK 1592613
CINCINNATI, OH
Position in CORT
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$680,644
+$209,783 QoQ
Shares Held
7,828
-33.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#33
of 92 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Formidable Asset Management, LLC holds $7,832,997 across 10 Biotechnology names. CORT ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
64,099 | $2,500,501 | |
| 2 | RPRX |
Royalty Pharma plc
|
32,010 | $1,794,800 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,518 | $1,747,496 | |
| 4 | CORT |
Corcept Therapeutics Inc
This page
|
7,828 | $680,644 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
847 | $528,138 | |
| 6 | TECH |
BIO-TECHNE Corp
|
5,017 | $354,451 | |
| 7 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
11,700 | $78,624 | |
| 8 | HELP |
Cybin Inc.
|
10,217 | $67,534 |
All Filings in CORT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680,644 | 7,828 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $470,861 | 11,681 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $216,838 | 6,231 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $720,231 | 8,666 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $636,084 | 8,666 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $891,715 | 7,807 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||